PuO2/X-ray/Relative effectiveness. Radiation-induced pulmonary carcinogenesis was compared in female Wistar rats following either inhalation exposure to alpha-emitting 239 PuO 2 aerosols, whole-body or thoracic X-ray irradiation. Dose-dependent survival reduction was correlated with increased malignant lung tumors at doses over 0.45 Gy, reaching the maximum incidence of 90% at 6.6-8.5 Gy in 239 Pu-exposed rats. While the differential dose responses for each histopathological type of tumors were noted, almost 70-80% were carcinomas among all of the primary tumors from 239 Pu-exposed rats. As the dose response curves for lung carcinomas were compared, the slope of the fit linear equation and the calculated relative effectiveness for 50% incidence of lung carcinomas were approximately 11-times as high in 239 Pu-exposure as those of thoracic X-irradiation. The numbers of tumor lesions distributed in the lung per tumor-bearing animal were about 2-fold more in 239 Pu-exposed rats, while the proportions of their histopathological types were similar between 239 Pu-exposure and X-irradiation. These results indicate that the magnitudes of the relative effectiveness or risk for pulmonary carcinogenesis are greater in 239 Pu-exposure than X-irradiation, and that radiation-induced lung tumors appear to originate mostly from the same target epithelial cells.
INTRODUCTION
The risk of human lung tumors derived from internal, i.e. inhalation exposure to plutonium or actinide compounds produced by nuclear facilities remains to be fully elucidated, since ICRP Publication 31 in 1980 summarized animal data on their biological effects. 1) While there are uncertainties in approaches to the risk estimation on human lung cancers due to plutonium and/or external radiations in U.S. nuclear workers, 2, 3) a series of epidemiological studies on Mayak nuclear workers recently suggested the significant and close association of inhaled plutonium compounds with lung cancer incidence and mortality. [4] [5] [6] Irrespective of such human data, animal studies on the lung cancer risk and related mechanisms are, however, essential to clarify variable factors for biokinetics, dosimetry, and biological effectiveness, as has been suggested by lifespan studies. 7) Animal studies on comparative carcinogenicity after inhalation exposure of rats to insoluble 238, 239 Pu, 244 Cm, and 241 Am dioxide aerosols [8] [9] [10] [11] have led to comprehensive results on lifetime pulmonary carcinogenesis in rats after inhalation exposure to 239 PuO2 aerosols. [12] [13] [14] In addition, large-scale experiments using beagle dogs have demonstrated the differences in carcinogenicity due to the solubility 15) and in biokinetics due to the aerosol particle size 16) of plutonium compounds, respectively. Such factors as solubility, particle size or specific activity of aerosols could strongly influence the dose distribution and the dose rate responsible for lung tumor induction. However, the relative biological effectiveness or the quality factor required for a risk estimation based on the same dosimetric unit, i.e. dose equivalent for the same target cells and tissues, has not been determined.
We have long performed lifespan studies on pulmonary carcinogenesis in rats following inhalation exposure to submicron and polydispersed, high-fired 239 PuO2 aerosols, and showed differential dose responses of lung tumor types 17) and pathogenetic processes.
18) The present study was done to summarize the final data from 239 Pu-exposed rats and to compare the effectiveness for pulmonary carcinogenesis with that of low linear energy transfer (LET) X-ray irradiation in the same strain of animals. The differences in carcinogenicity and related mechanisms from the other alpha-emitting actinides or radiation sources are discussed.
MATERIALS AND METHODS

Animals
Because of easier handling for long-term animal care and the lower incidences of spontaneous lung tumors, female Wistar (W/M) strain rats purchased from a breeding colony (Japan SLC Co.) were used for either inhalation exposure to plutonium dioxide aerosols or X-ray irradiation at the age of 100 to 120 days after birth, as previously described. 13, 14, 17) Before and after all of the experiments, animals were housed 5 per polycarbonate cage in a closed hood rack for groups of plutonium-exposed rats or 5 per stainless-steel cage in a cascade cage rack for the groups of X-irradiated rats, respectively, and kept under a barrier-filtered air condition with a commercial diet (Funabashi Farm Co.) and water ad libitum. All of the animal rooms were maintained on a 12-h light:dark cycle at a room temperature of 23 ± 1.0°C with a humidity of 55 ± 5.0%. The animal care included a weekly change of cages and a daily check of the animals' condition during their lifetimes. All of the experimental treatments were performed with the approval of the institution's animal use committee.
Inhalation exposure and dose calculation
As previously described, 17, 18) a plutonium hydroxide solution prepared from a stock nitrate solution was nebulized in a compressed air-driven nebulizer, passed through a tube heated at 300°C to dry the droplets in the air, and then conducted into a high-temperature furnace heated at 1,150°C to make high-fired 239 PuO2 aerosols with an average of activity median aerodynamic diameter (AMAD) of 0.40 ± 0.005 µm and an average of geometric standard deviation (GSD) of 2.2 ± 0.1. The air flow containing such polydispersed and submicron aerosols was introduced through a negative pressure by an exhaust air pump into a multiport inhalation chamber device in which 20 animals per each experiment were placed into a plastic holder for a noseonly exposure once for the minimum of 5 min to the maximum of 60 min to 239 PuO2 aerosols. The initial lung deposition of each exposed animal was determined by whole-body counting of the low-energy (17 keV) LX-rays emitted from 239 Pu deposited in the lung 7 days after the exposure, as described previously, 17) ranged from the minimum of 7 Bq to the maximum of 2,200 Bq in the present study. The cumulative alpha-particle dose absorbed in the whole lung was calculated at the time of death by using the time integral of the initial lung deposition and the retention function obtained from the follow-up whole-body counting of another 20 exposed animals until 400 days after the exposure, ranged from the minimum of 0.05 Gy to the maximum of 10.5 Gy in the present study.
X-ray irradiation and dose measurement
We initially tried to achieve intermittent and fractionated whole-body X-irradiation (WBX) using X-rays of 200 kVp and 6.0 mA with 0.5 mm Cu and 0.5 mm Al filters and with FSD (field-source-distance) of 100 cm at a dose rate of 0.1 Gy/min using Pantak HF 320S (Shimadzu). Five animals per each irradiation were exposed repeatedly, 3-times a week, in a cylindrical Lucite holder with 6-separated chambers to fractionated X-rays by a split dose of 0.5 Gy to achieve a total accumulated dose of 0.5 to 10 Gy. For local, thoracic X-irradiation (ThX), 5 animals per each irradiation were anesthetized with intraperitoneal injection of sodium pentbarbital, and exposed once in a rectangular Lucite holder separated by 6 chambers, shielded with a 5 mmthick lead sheet, except for the thorax, to a single dose of X-rays of 200 kVp and 20 mA with 0.5 mm Cu and 0.5 mm Al filters and with FSD of 75 cm at a dose rate of 0.6 Gy/min to achieve a total accumulated dose of 1.0 to 10 Gy. Dosimetry was carried out during all irradiation processes with a 0.6 ml C-110 ionization chamber in conjunction with a thermoluminescent dosemeter (model AE-1321M, Applied Engineering Inc.) put onto the central or thoracic position of an empty chamber of the Lucite holder used for both irradiation regimens. The average total accumulated dose measured by the above dosimetry was regarded as the absorbed dose in the whole lung of each experimental group.
Pathological examinations
Postmortem pathological examinations were performed on all the dead or moribund and sacrificed animals from all of the experimental groups, except for those which lost main organs by cannibalism or were severely autolysed. At autopsy, the gross lesions were carefully examined, particularly on the distribution of neoplastic lesions in each lobe of the lung, and other parts of the respiratory tracts. The whole lungs and the other main organs, except for the central nervous system, were fixed in 10% phosphate-buffered formalin, dissected into either at least a total 15 sagittal sections from the whole lung lobes as well as tumor mass, or a few small pieces from each of the other main organs, processed with graded ethanol and xylene in an automatic tissue processor. They were then embedded in paraffin. Five to 6 µm-thick sections were prepared from each paraffin-embedded tissue block, and stained routinely with hematoxylin and eosin (HE) for light microscopic examinations. Differential diagnoses of the primary lung tumors from metastatic tumors and between histopathological types of tumors were performed morphologically, according to those criteria described. 19, 20) Almost all of the primary lung tumors, except for only a few percentage of nonepithelial types, such as fibrosarcomas and hemangiosarcomas, were classified into 4 epithelial types: benign adenomas and malignant carcinomas including adenocarcinomas, adenosquamous carcinomas and squamous cell carcinomas. The numbers of these epithelial types of lung tumor lesions distributed in the whole lung were estimated by enumerating those numbers observed in serial sections prepared from at least 15 sagittal tissue sections of the whole lung lobes from each tumor-bearing animal.
Statistics
The survival period after 239 Pu-exposure or X-irradiation was analysed for the competing risk of neoplastic or non-neoplastic death by Kaplan-Meier non-parametric analysis, and compared as well as primary lung tumor incidences for statistically significant differences between the control and 239 Pu-exposed or Xirradiated groups using Student's t-test. The standard errors for the primary lung tumor incidences were calculated using the following formula 21) :
, where p is the proportion of animals with lung tumors and n the total number of animals examined in each group.
A linear regression analysis based on the least-squares method was applied to the dose response curves of lung carcinomas from both 239 Pu-exposed and X-irradiated rats to introduce a fit linear equation with square correlation coefficients, as described.
22)
RESULTS
Dose and survival periods
As shown in Table 1 , total 600 239 PuO2-exposed rats were divided into 8 groups (Pu 1 to Pu 8) based on the mean values of the intial lung deposition and lung dose from 0.16 Gy to 8.52 Gy. As compared to the control group of total 206 unexposed animals, the mean survival periods of the groups (Pu 2-Pu 8) of rats that received mean lung doses of more than 0.45 Gy were significantly (p < 0.01 or 0.001) reduced, while that of the group (Pu 1) of rats that received the lowest dose of 0.16 Gy was not significantly different from the controls. Among the primary lung tumors observed, benign tumors, all the adenomas, showed incidences of 20-24% at lower to middle doses of 0.16-2.76 Gy, but then decreased down to the bottom at higher doses of 4.67-8.52 Gy. In contrast, the incidence of malignant tumors, including carcinomas and a few sarcomas, was not significantly different in the lowest dose group (Pu 1) that received 0.16 Gy from that The numbers and percent incidence ± SE in parenthesis of tumor-bearing animals examined in each group. Benign tumors are adenomas, and malignant tumors include all the carcinomas and a few sarcomas. Asterisks indicate a significant difference compared to the controls (*p < 0.01, **p < 0.001). The numbers and percent incidence ± SE in parenthesis of tumor-bearing animals examined in each group. Benign tumors are adenomas, and malignant tumors include all the carcinomas and a few sarcomas. Asterisks indicate a significant difference compared to the controls (*p < 0.01, **p < 0.001).
of the controls, but significantly and drastically increased up to the maximum of about 90% at doses of 0.45-6.61 Gy, and then reached a plateau at 6.61-8.52 Gy. These findings indicate that significant survival reduction was well correlated with the increase of malignant lung tumors from 239 PuO 2 -exposed rats that received a mean lung dose of 0.45 Gy or more. Malignant tumors appeared relatively early from 350 days to the middle periods of 500 days after exposure (data not shown).
On the other hand, a total of 275 whole-body X-irradiated rats and a total of 292 thoracic X-irradiated rats were divided into 6 groups (A to F) and 4 groups (G to J), respectively. As compared to each control group, the mean survival periods were significantly (p < 0.01 or 0.001) reduced at 2.0 Gy or more in wholebody X-irradiated rats and at 5.0 Gy or more in thoracic X-irradiated rats, respectively (Table 2 ). Both benign and malignant lung tumors from whole-body X-irradiated rats were significanly observed, but with lower frequencies at doses of 2.0-10 Gy, whereas those from thoracic X-irradiated rats significantly increased at doses of 3.0-5.0 Gy, and reached the maximum of only 15-24% at the highest dose of 10 Gy. Thus, the incidences of primary lung tumors, particularly malignant ones, were much lower in both X-irradiated rats than those of 239 PuO 2 -exposed rats, indicating that significant survival reduction observed at higher doses of more than 3.0 or 5.0 Gy of X-irradiation was not correlated with the increase of malignant lung tumors, but was rather due to an early increase of the other solid tumors, such as mammary and ovary tumors (data not shown).
Dose and lung tumor incidences
Primary lung tumors from both 239 PuO 2 -exposed and X-irradiated rats were classified mostly into 4 epithelial types (adenomas, adenocarcinomas, adenosquamous carcinomas and squamous cell carcinomas) and only a few non-epithelial types (fibrosarcomas and hemangiosarcomas), as described in materials and methods. As shown in Table 3 , the incidence of adenomas from 239 PuO 2 -exposed rats reached a plateau of 20-24% at lower to middle doses of 0.16-2.76 Gy, then declined down to the bottom at the higher doses of 4.67-8.52 Gy, while the remaining 70-80% of primary tumors were carcinomas, showing differential dose responses for each histopathological type: adenocarcinomas increased drastically up to a maximum of about 50% at middle doses of 1.59-2.76 Gy, then reduced slightly down to a plateau of 32-35% at higher doses of 4.67-8.52 Gy; adenosquamous carcinomas increased drastically at doses of 4.67 Gy or more, then reached a maximum of about 50% at the highest dose of 8.52 Gy; squamous cell carcinomas were, however, fewer than the other epithelial types of tumors to show only slight increase at higher doses of 4.67-6.61 Gy. In contrast, almost 80-90% of the primary lung tumors from both X-irradiated rats were adenomas and adenocarcinomas, whereas adenosquamous and squamous cell carcinomas were scarce ( Table 3 ). The incidences of both adenomas and adenocarcinomas from whole-body X-irradiated rats were, however, much lower, while adenomas and adenocarcinomas from thoracic Xirradiated rats prominently increased up to incidences of 13-24% only at higher doses of 5.0-10 Gy to show a significant dose response, respectively. Thus, together with the above findings on 239 Pu-induced lung tumors, dose response curves for primary lung carcinomas are available for comparisons between 239 PuO2-exposed and thoracic X-irradiated rats.
Comparisons of fit linear dose response curves for lung carcinomas
Because almost all of the malignant lung tumors from 239 PuO2-exposed rats were carcinomas, and a significant dose response of lung carcinomas from thoracic X-irradiated rats was only available for comparisons, as described above, a linear regression analysis was done for both dose response curves of lung carcinomas from 239 PuO2-exposed and thoracic X-irradiated rats. As shown in Fig. 1, a Pu appeared to be approximately 11-fold of that from ThX. The effective doses for 50% incidence of lung carcinomas were calculated from these linear equations shown in Fig. 1 PuO2-exposure and thoracic X-irradiation.
Histopathology of lung tumor lesions
Typical histopathological features of each lung tumor type from 239 PuO2-exposed rats are shown in Fig. 2 . Most of the epithelial types of tumors were found either in the bronchiolo-alveolar or peripheral and subpleural alveolar regions, while only a few squamous cell carcinomas were distributed in the bronchial or bronchiolar regions. All of the adenomas were localized, and appeared to show ductal forms with columnar or cuboidal epithelium ( Fig. 2A) , or sometimes papillary structures surrounded by a monolayer of cuboidal epithelium with the connective tissue stroma, as shown in Fig. 2B . Adenocarcinomas were more extensively distributed in the alveolar sacs or bronchiolar lumens to make multiple foci, mostly showing papillary and intraductal growth of variable-sized and irregular-shaped epithelial cells (Fig. 2C) , or occasionally solid appearances due to closely compact growth of large epithelial cells (Fig. 2D) . Adenosquamous carcinomas were found, mostly in areas adjacent to the foci of such solid adenocarcinomas, to show pearl-like structures of concentrically growing epithelial cells with none, or lesser, keratinization, as shown in Fig. 2E , while squamous cell carcinomas appeared to show more irregular-shaped, pearl-like structures with amounts of keratin (Fig. 2F ) and mostly contained necrotic cellular debris inside the carcinoma foci.. These histopathological appearances of 239 PuO2-induced lung tumor types were similar to those of X ray-induced tumor types, and the proportions of each histopathological type of lung tumor lesions distributed in the lungs from all the 239 PuO2-exposed tumor-bearers were also similar to those from both X-irradiated tumor-bearers (Fig. 3) . Thus, almost 50% were adenomas, 30-40% adenocarcinomas, and 10-20% adenosquamous and squamous cell carcinomas, respectively. The numbers of lung tumor lesions were, however, different as compared among the 239 PuO2-exposed and X-irradiated tumor-bearers. As shown in Table 4 , the average numbers of adenomatous lesions distributed in the lung per a tumor-bearing animal from 239 PuO2-exposed and both of X-irradiated groups were not different, despite some variety among doses, while the average numbers of carcinomatous lesions per 239 PuO2-exposed tumor-bearers, were approximately 2-fold more than those of both X-irradiated tumorbearers, particularly at higher doses of more than 4-5 Gy. The microscopic sizes of these carcinomatous lesions also appeared to be larger in 239 PuO2-exposed rats than in X-irradiated rats (data not shown). 
DISCUSSION
In the present study, the dose-dependent survival reduction, due to the increased and relatively early occurring carcinomas after inhalation exposures of rats to 239 PuO2, was only apparent at more than 0.45 Gy, but not significantly observed at the lowest dose of 0.16 Gy. This clearly indicates the plausible thresholdlike dose around 0.16 Gy for the survival reduction and induction of carcinomas, as has been described previously to be noted around 0.5-1.0 Gy. 12, 13, 17) The relevance of lung carcinomas with lower frequencies from both whole-body or thoracic X-irradiated rats to the significant survival reduction even at higher doses was, however, considered to be much less while, instead, malignant and occasionally metastatic solid tumors, such as ovary and mammary carcinomas, other than the primary lung tumors, might influence early neoplastic death, leading to survival reduction.
While the dose response for lung carcinomas, accounting for almost 70-80% of all primary lung tumors from 239 PuO2-exposed rats, was much different from those of both whole-body PuO2-exposure or X-irradiation. The percent proportions of each lung tumor lesions, adenomas (AD), adenocarcinomas (AC), adenosquamous carcinomas (ASC), squamous cell carcinomas (SCC) and other types including fibrosarcomas or hemangiosarcomas, are shown among all of the tumor lesions found after inhalation exposure to 239 PuO2 (Pu), and whole-body X-irradiation (WBX) or thoracic X-irradiation (ThX), respectively. and thoracic X-irradiated rats, only the dose response curve for lung carcinomas from thoracic X-irradiated rats was available for a comparison with that of carcinomas from 239 PuO 2 -exposed rats. Because the slope of the fit linear curve and the calculated relative effectiveness for 50% incidence of lung carcinomas were estimated to be about 11-times as high in 239 Pu-induced carcinomas as those of thoracic X-induced carcinomas, the differences in the relative effectiveness or risk for pulmonary carcinogenesis would be larger, as expected between 239 Pu and Xrays. The rat lung tumors induced by both whole-body and thoracic X-irradiation have also been documented to show a lower incidence of at most 6.6%, even at the highest accumulated thoracic dose of 38 Gy in Fischer 344 rats, 23) while the exposure to high-LET radiations, such as neutrons, and radon and progeny could induce more lung tumors in Sprague-Dawley rats with higher relative biological effectiveness of about 50 or more, as compared to low-LET γ-rays. 24) In addition, there have been some descriptions on the differences in dose responsiveness and lung tumor types induced in rats following either fission fragment irradiation or exposure to enriched uranium oxide, 25) fission neutron exposure, as compared to γ-ray irradiation, 26) β-ray irradiation by inhalation exposure to insoluble 144 Ce-infused alminosilicate aerosols, 27, 28) or α-particle irradiation by inhalation exposure to uranium ore dust. 29) Because of variable irradiation regimens and the dose rates used in these studies, comparisons with the present results are not easy to introduce differences in the relative effectiveness or radiation quality in pulmonary carcinogenesis, but it appears that the incidence and types of rat lung tumors would be rather more dependent on the radiation quality than on the radiation doses distributed in the lung.
In addition to the 11-fold difference in the relative effectiveness for carcinogenesis, the numbers of carcinoma lesions distributed in the lung per tumor-bearing animal were 2-fold more in 239 PuO 2 -exposure than in both types of X-irradiation, implicating the differences, as well as the sizes of the foci, in the extent of severity of carcinoma lesions. Irrespectively, the proportions of each histopathological type of lung tumor lesions distributed in the lung were similar, as shown by the proportions of approximately 80-90% adenomas and adenocarcinomas, and 10-20% adenosquamous and squamous cell carcinomas, in both 239 PuO 2 -exposure and X-irradiation, suggesting that most of primary lung tumors, adenomas and adenocarcinomas, induced by α-particles from 239 Pu or by X-rays, despite the differences in the dose and effectiveness, originate from the same target epithelial cells, such as alveolar type II pneumocytes and/or bronchiolar Clara cells, as previously described, 30) and supported by the review of the ICRP Publication 66 (1994) 31) and the NCRP report (1997).
32)
Among α-emitting actinides, there seems to be a variety in the dose responsiveness of malignant lung tumors in rats following , as compared to 239 Pu compounds. Such differences as the relative effectiveness or risk for pulmonary carcinogenesis appeared to be due to a larger dose delivery resulting from the aggregation of inhaled 239 PuO2 aerosol particles in the pulmonary fibrotic scar tissues, [35] [36] [37] whereas the contradictory results and implications were obtained concerning pre-existing pulmonary fibrosis, which appeared to modify to a lesser extent the initial lung deposition of inhaled 239 PuO2 aerosols, dose delivery to the target epithelial cells, and the resultant pulmonary carcinogenesis in rats as compared between groups with similar alpha doses to the lung. 38) Otherwise, either homogenous dose distribution, such as exposure to radon and uranium ore dust, or specific activity of non-uniformly deposited aerosol particles, such as actinides, might influence more the risk for pulmonary carcinogenesis. 22) As described previously in our paper, 17) the dose responsiveness as well as lung tumor types were different as compared among three experiments, including ours, performed in rats exposed to 239 PuO2 aerosols with different particle sizes. 12, 14) In consideration of the descriptions of both ICRP and NCRP reports 31, 32) that the deposition and dose distribution of inhaled aerosol particles in the respiratory tract depend on the aerosol size, submicron aerosols with AMAD of 0.4 µm (estimated geometric diameter of 0.1-0.2 µm) in our experiments may induce a more uniform alpha particle dose distribution to irradiate more efficiently target epithelial cells distributed in the bronchiolo-alveolar regions with lower dose rate as compared to the other two experiments using aerosols with AMAD of 1.0-1.5 µm (estimated geometric diameter of 1.0-2.0 µm), which probably cause particle aggregations in the fibrotic scar, as described elsewhere, [35] [36] [37] and a more non-uniform dose distribution with a higher dose rate, resulting in a shift of the peak incidence of lung carcinomas from the lower to higher dose ranges, and an increased proportion of squamous cell carcinomas in the bronchial to bronchiolar regions. Such speculation would be available for the present results that adenomas in the alveolar regions were still more frequently observed at lower doses below 1.59 Gy, and adenocarcinomas increased up to the maximum incidence of 50% at the middle dose of 2.76 Gy, while adenosquamous or squamous cell carcinomas increased at higher doses of more than 4.67 Gy, respectively. Such trends for differential dose responses of carcinoma types are consistent with those results that adenocarcinomas are more frequently induced by lower doses less than 1.4 Gy, while squamous carcinomas increased at higher doses of more than 8.0 Gy, implicating the dose rate effects due to non-uniform distribution of aggregated aerosol particles in the fibrotic scar, as described. 37) Concerning the dose-rate effects of a uniform alpha particle distribution on pulmonary carcinogenesis, there has, however, been an argument on the reverse doserate effects either in lower dose ranges below 25 WLM (working level month) or higher dose ranges over 1,000 WLM of inhalation exposure of rats to radon and progeny on the incidences of pulmonary cancers, [39] [40] [41] even though alpha particles from gaseous or ultrafine attached aerosol elements of radon and progeny could more uniformly irradiate target epithelial cells, irrespective of different dose rates.
In conclusion, we have shown the following results by lifetime animal experiments using 600 239 Pu-exposed and almost 600 Xirradiated female Wistar rats: the magnitudes of the relative effectiveness or risk for pulmonary carcinogenesis were approximately 11-fold greater in 239 Pu-exposure than those of thoracic X-irradiation, and the numbers of lung tumor lesions distributed in the lung of tumor-bearing animals were about 2-fold different, while their proportions of each histopathological type were almost similar between 239 Pu-exposed and both X-irradiated rats, suggesting that lung tumors induced by alpha particles or X-irradiation appear to originate mostly from the same target epithelial cells.
